Ann Transplant 2005; 10(3): 46-46
A current challenge in renal transplantation is to develop immunosuppressive regimens without adverse effects including nephrotoxicity and cardiovascular risk. A significant number of presentations were focused on steroid or caliceurin inhibitor avoidance regimens. New immunosuppressive agents compensated steroid or CNI avoidance have become available. A novel strategy includes minimising of maintenance immunosuppression through the
aggressive use depletion induction therapy.